tiprankstipranks
Trending News
More News >
Kala Pharmaceuticals Inc (KALA)
NASDAQ:KALA
US Market

Kala Pharmaceuticals (KALA) Income Statement

Compare
1,449 Followers

Kala Pharmaceuticals Income Statement

Last quarter (Q1 2025), Kala Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Kala Pharmaceuticals's net income was $-8.95M. See Kala Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 3.89M$ 11.24M$ 6.36M
Gross Profit
$ 0.00$ -303.00K$ 1.33M$ 7.14M$ 3.19M
Operating Expenses
$ 40.43M$ 38.85M$ 82.69M$ 116.58M$ 99.42M
Depreciation and Amortization
$ 3.31M$ 303.00K$ 860.00K$ 2.27M$ 2.84M
EBITDA
$ -40.98M$ -36.08M$ -36.70M$ -131.96M$ -92.90M
Operating Income
$ -40.98M$ -39.15M$ -81.36M$ -109.43M$ -96.23M
Other Income/Expenses
$ 2.47M$ -3.05M$ 36.53M$ -12.36M$ -8.10M
Pretax Income
$ -38.51M$ -42.20M$ -44.82M$ -142.60M$ -104.33M
Net Income
$ -38.51M$ -42.20M$ -223.00K$ -152.30M$ -112.00M
Per Share Metrics
Basic EPS
$ -1.01$ -17.35$ -0.15$ -116.79$ -106.92
Diluted EPS
$ -1.01$ -17.35$ -0.15$ -116.79$ -106.92
Weighted Average Shares Outstanding
37.96M 2.43M 1.52M 1.30M 1.05M
Weighted Average Shares Outstanding (Diluted)
37.96M 2.43M 1.52M 1.30M 1.05M
Currency in USD

Kala Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis